£1.6M
Cedars-Sinai and Oxford Science Enterprises backed the seed round to support expansion into the American market.
"The research produced at Oxford is of the highest caliber. An ongoing relationship with OSE will serve our patients and also strengthen the academic and clinical missions of Cedars-Sinai."